These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36568122)

  • 21. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
    Huang BS; White RA; Ahmad M; Leenen FH
    Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone synthase inhibitors in cardiovascular and renal diseases.
    Namsolleck P; Unger T
    Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i62-i68. PubMed ID: 24493871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promise of selective aldosterone synthase inhibition for the management of resistant hypertension.
    Volpe M; Patrono C
    Eur Heart J; 2023 Feb; 44(8):641-642. PubMed ID: 36540035
    [No Abstract]   [Full Text] [Related]  

  • 24. Aldosterone Synthase in Peripheral Sensory Neurons Contributes to Mechanical Hypersensitivity during Local Inflammation in Rats.
    Mohamed DM; Shaqura M; Li X; Shakibaei M; Beyer A; Treskatsch S; Schäfer M; Mousa SA
    Anesthesiology; 2020 Apr; 132(4):867-880. PubMed ID: 32011337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors.
    Feldman JM; Frishman WH; Aronow WS
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38358268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone and arterial hypertension.
    Tomaschitz A; Pilz S; Ritz E; Obermayer-Pietsch B; Pieber TR
    Nat Rev Endocrinol; 2010 Feb; 6(2):83-93. PubMed ID: 20027193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?
    Schneider MP; Hilgers KF
    Hypertension; 2017 Jan; 69(1):11-12. PubMed ID: 27872235
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of aldosterone levels by -344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension.
    Fontana V; de Faria AP; Barbaro NR; Sabbatini AR; Modolo R; Lacchini R; Moreno H
    J Am Soc Hypertens; 2014 Mar; 8(3):146-51. PubMed ID: 24388430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease.
    Awosika A; Khan A; Adabanya U; Omole AE; Millis RM
    Cureus; 2023 Mar; 15(3):e36184. PubMed ID: 36937127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice.
    Gu H; Ma Z; Wang J; Zhu T; Du N; Shatara A; Yi X; Kowala MC; Du Y
    Sci Rep; 2017 Mar; 7(1):492. PubMed ID: 28352088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone and aldosterone antagonism in systemic hypertension.
    Frishman WH; Stier CT
    Curr Hypertens Rep; 2004 Jun; 6(3):195-200. PubMed ID: 15128471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.
    Sydorchuk L; Dzhuryak V; Sydorchuk A; Levytska S; Petrynych V; Knut R; Kshanovska A; Iftoda O; Tkachuk O; Kyfiak P; Popovich A; Khomko O; Sydorchuk R
    Endocr Regul; 2020 Jul; 54(3):217-226. PubMed ID: 32857720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST).
    Brand E; Schorr U; Ringel J; Beige J; Distler A; Sharma AM
    J Hypertens; 1999 Nov; 17(11):1563-7. PubMed ID: 10608469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure.
    Furuzono S; Meguro M; Miyauchi S; Inoue S; Homma T; Yamada K; Tagawa YI; Nara F; Nagayama T
    Eur J Pharmacol; 2017 Jan; 795():58-65. PubMed ID: 27915044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. This is not Dr. Conn's aldosterone anymore.
    Brown NJ
    Trans Am Clin Climatol Assoc; 2011; 122():229-43. PubMed ID: 21686229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
    Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
    Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
    Sloan-Lancaster J; Raddad E; Flynt A; Jin Y; Voelker J; Miller JW
    J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317717883. PubMed ID: 28814143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway.
    Huang BS; Ahmadi S; Ahmad M; White RA; Leenen FH
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H422-30. PubMed ID: 20511409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone synthase inhibition in hypertension.
    Andersen K
    Curr Hypertens Rep; 2013 Oct; 15(5):484-8. PubMed ID: 23917810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.